Back
Brookfield Renewable Vs. Aligos Therapeutics Industry Stock Comparison
Buy
52
BEPC
Brookfield Renewable
Last Price:
29.66
Seasonality Move:
-7.06%
Buy
75
ALGS
Aligos Therapeutics
Last Price:
34.37
Seasonality Move:
10.65%
Buy
52
Brookfield Renewable (BEPC)
is a Buy
Is Brookfield Renewable a Buy, Sell or Hold?
- The current Brookfield Renewable [BEPC] share price is $29.89. The Score for BEPC is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- BEPC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
- The current Aligos Therapeutics [ALGS] share price is $34.53. The Score for ALGS is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BEPC Stock Price Chart
What is Brookfield Renewable's stock price today?
-
The Brookfield Renewable share price today is $29.89
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BEPC is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $34.53
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
BEPC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.33 | Sell |
| Relative Strength Index (14 RSI): | 43.6 | Sell |
| Chaikin Money Flow: | 1061761 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.85 - 31.69) | Sell |
| Bollinger Bands (100): | (28.24 - 31.92) | Sell |
ALGS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.71 | Buy |
| Relative Strength Index (14 RSI): | 85.17 | Buy |
| Chaikin Money Flow: | 491004 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.08 - 27.66) | Buy |
| Bollinger Bands (100): | (7.67 - 19.61) | Buy |
BEPC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.45 | Sell |
| 20-day SMA: | 30.85 | Sell |
| 50-day SMA: | 31.28 | Sell |
| 200-day SMA: | 28.69 | Buy |
| 8-day EMA: | 30.26 | Sell |
| 20-day EMA: | 30.74 | Sell |
| 50-day EMA: | 30.83 | Sell |
| 200-day EMA: | 29.54 | Buy |
ALGS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.48 | Buy |
| 20-day SMA: | 23.64 | Buy |
| 50-day SMA: | 14.76 | Buy |
| 200-day SMA: | 15.86 | Buy |
| 8-day EMA: | 28.77 | Buy |
| 20-day EMA: | 23.99 | Buy |
| 50-day EMA: | 18.16 | Buy |
| 200-day EMA: | 16.13 | Buy |
Brookfield Renewable Earnings Growth & BEPC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and a decrease next year of $0.58 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
Brookfield Renewable Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aligos Therapeutics Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||